A phase 3, single-arm, open-label study to evaluate the safety, tolerability, and immunogenicity of a 15-valent pneumococcal conjugate vaccine, V114, in a 3+1 regimen in healthy infants in South Korea (PNEU-PED-KOR)

Volume 20, Issue 1, December 2024 .

Source: Human Vaccines and Immunotherapeutics - March 18, 2024 Category: Allergy & Immunology Authors: Alvino MaestriSu Eun ParkFiona FernandesZhongyi “Lucy” LiYae-Jean KimYun-Kyung KimJin LeeJi Young ParkDong Hyun KimGyongSeon YangHyunjung LimJin Oh KimRobert LupinacciTina M. SterlingMarissa WilckAlejandra Esteves-JaramilloNatalie Banniettisa MRL, Mer Source Type: research